Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report

Table 1 Reported cases of cyclophosphamideinduced posterior reversible encephalopathy syndrome in patients with rapidly progressive glomerulonephritis

Ref.	Age (yr)	Sex	Country	Renal diagnosis	Immunosuppressant	BP (mmHg)	SCr (mg/dL)	Onset of PRES after CP (d)	Recovery time (d)
Abenza-Abildua et al[3]	27	F	Spain	Anti-GBM disease	Pulse Pd, IV CP	185/105	8.5	30	2
Lee et al[4]	45	F	South Korea	Lupus nephritis	Pulse Pd, IV CP	190/100	2.68	16	20
Scailteux et al[5]	75	M	France	ANCA vasculitis	Pulse Pd, IV CP	164/91	2.40	3	18
Jabrane et al[11]	16	F	Morocco	Lupus nephritis	Pulse Pd, IV CP	120/70	5.8	3	1
Pan et al[6]	22	F	United States	ANCA vasculitis	Pulse Pd, IV CP	170/110	1.47	3	NR
Cha et al[7]	36	F	South Korea	Anti-GBM disease	Pulse Pd, oral CP	200/120	4.7	90	28
Zekić et al[16]	18	F	Croatia	Lupus nephritis	Pulse Pd, IV CP	160/100	Normal	14	45
Ganesh et al[8]	25	F	India	H-S purpura	Pulse Pd, oral CP	Normal	Moderate RF	26	NR
Present	73	M	South Korea	ANCA vasculitis	Pulse Pd, oral CP	175/76	5.47	3	7

ANCA: Anti-neutrophil cytoplasmic antibody; BP: Blood pressure; CP: Cyclophosphamide; H-S: Henoch-Schönlein; IV: Intravenous; GBM: Glomerular basement membrane; GN: Glomerulonephritis; NR: Not reported; Pd: Prednisolone; PRES: Posterior reversible encephalopathy syndrome; RF: Renal failure, RPGN: Rapidly progressive GN.